Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted the company’s IRO platform an Advanced Manufacturing ...
MPM Medical today announced a major expansion of its U.S. manufacturing capabilities with the acquisition of a full collagen manufacturing platform and the associated FDA 510 (k) clearance for ...
CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--LumaCyte, a trailblazer in advanced label-free cellular bioanalytical technology and instrumentation, proudly announces the launch of the Laser Force Cytology™ ...
WHITE OAK, Md.--(BUSINESS WIRE)--The Food and Drug Administration’s (FDA) Office of Counterterrorism and Emerging Threats (OCET) has awarded a contract worth over $1.78M to Siemens Government ...
Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...
Syrma Johari’s leadership shared a similar sentiment, noting that the partnership reflects a strong alignment in innovation, quality, and long-term vision, and that it is pleased to support INBS in ...
The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...
A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.
New production capacity strengthens MPM Medical's position as a leading U.S. manufacturer and follows the company's recent launch of collagen at-home wound care kits MESQUITE, Texas, Dec. 16, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback